Rashna Madan

38.9k citations
65 papers · 869 indexed · h-index 18
Topics
Cancer Immunotherapy and Biomarkers (9 papers)Gastric Cancer Management and Outcomes (8 papers)Pancreatic and Hepatic Oncology Research (7 papers)

In The Last Decade

Rashna Madan

58 papers receiving 847 citations

Peers

Rashna Madan
Comparison fields: 5 of 87
  • Oncology 368
  • Molecular Biology 316
  • Cancer Research 188
  • Immunology 152
  • Pathology and Forensic Medicine 142
Replace Koroku Kato with:
Koroku Kato Japan
Karen D. Cowden Dahl United States
Rebeca Galisteo United States
Jason R. Neil United States
Nilay S. Sethi United States
Sylvie Thuault France
Marı́a L. Lamelas Spain
Yuan Mao China
Elisa Melucci Italy
Nuno R. dos Santos Portugal
Rashna Madan relative to Koroku Kato Japan Koroku Kato's profile →
Citations per field
00.5×2.8×
Koroku Kato · 1×
Citations per year

Countries citing papers authored by Rashna Madan

Since Specialization
Citations

This map shows the geographic impact of Rashna Madan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rashna Madan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rashna Madan more than expected).

Fields of papers citing papers by Rashna Madan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rashna Madan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rashna Madan. The network helps show where Rashna Madan may publish in the future.

Co-authorship network of co-authors of Rashna Madan

This figure shows the co-authorship network connecting the top 25 collaborators of Rashna Madan. A scholar is included among the top collaborators of Rashna Madan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rashna Madan. Rashna Madan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 3
3 12
4 1
5 9
6 2
7 0
8 26
9 4
10 18
11 4
12 37
13 26
14 21
15 8
16 17
17 50
18 2
19 75
20 1

About Rashna Madan

Rashna Madan is a scholar working on Oncology, Cancer Research and Pathology and Forensic Medicine, having authored 65 papers that have together received 869 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (9 papers), Gastric Cancer Management and Outcomes (8 papers) and Pancreatic and Hepatic Oncology Research (7 papers). The work is most often cited by research in Oncology (368 citations), Cancer Research (188 citations) and Immunology and Allergy (55 citations). Rashna Madan has collaborated with scholars based in United States, United Kingdom and India. Frequent co-authors include Jeremy Chien, Ossama Tawfik, Andrew K. Godwin, Maura O’Neil, Chad Slawson, Rafaela Muniz de Queiroz, Wagner B. Dias, Maja H. Oktay, Rana Fayyad and Fang Fan. Their work appears in journals such as Journal of Biological Chemistry, Nature Communications and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026